Cargando…
Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats
BACKGROUND: Seed of mature Croton tiglium Linne, also known as Tiglium seed (TS), has been widely used as a natural product due to its several health beneficial properties including anti-tumor and antifungal activities. Despite its ethnomedicinal beneficial properties, toxicological information rega...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134578/ https://www.ncbi.nlm.nih.gov/pubmed/30208908 http://dx.doi.org/10.1186/s12906-018-2315-5 |
_version_ | 1783354685410770944 |
---|---|
author | Yun, Jun-Won Kwon, Euna Kim, Yun-Soon Kim, Seung-Hyun You, Ji-Ran Kim, Hyoung-Chin Park, Jin-Sung Che, Jeong-Hwan Lee, Sang-Koo Jang, Ja-June Kim, Hyeon Hoe Kang, Byeong-Cheol |
author_facet | Yun, Jun-Won Kwon, Euna Kim, Yun-Soon Kim, Seung-Hyun You, Ji-Ran Kim, Hyoung-Chin Park, Jin-Sung Che, Jeong-Hwan Lee, Sang-Koo Jang, Ja-June Kim, Hyeon Hoe Kang, Byeong-Cheol |
author_sort | Yun, Jun-Won |
collection | PubMed |
description | BACKGROUND: Seed of mature Croton tiglium Linne, also known as Tiglium seed (TS), has been widely used as a natural product due to its several health beneficial properties including anti-tumor and antifungal activities. Despite its ethnomedicinal beneficial properties, toxicological information regarding TS extract, especially its long-term toxicity, is currently limited. Therefore, the objective of the present study was to evaluate acute and subchronic toxicity of TS extract in rats after oral administration following test guidelines of the Organization for Economic Cooperation and Development (OECD). METHODS: Toxicological properties of TS extract were evaluated by toxicity assays to determine its single-dose acute toxicity (125, 250, 500, 1000, or 2000 mg/kg), 14-day repeated-dose toxicity (125, 250, 500, 1000, or 2000 mg/kg) and 13-week repeated-dose toxicity (31.25, 62.5, 125, 250, and 500 mg/kg) in Sprague-Dawley rats and F344 rats. Hematological, serum biochemical, and histopathological parameters were analyzed to determine its median lethal dose (LD(50)) and no-observed-adverse-effect-level (NOAEL). RESULTS: Oral single dose up to 2000 mg/kg of TS extract resulted in no mortalities or abnormal clinical signs. In 13-week toxicity study, TS extract exhibited no dose-related changes (mortality, body weight, food/water consumption, hematology, clinical biochemistry, organ weight, or histopathology) at dose up to 500 mg/kg, the highest dosage level suggested based on 14-day repeat-dose oral toxicity study. CONCLUSION: Acute oral LD(50) of TS extract in rats was estimated to be greater than 2000 mg/kg. NOAEL of TS extract administered orally was determined to be 500 mg/kg/day in both male and female rats. Results from these acute and subchronic toxicity assessments of TS extract under Good Laboratory Practice regulations indicate that TS extract appears to be safe for human consumption. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12906-018-2315-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6134578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61345782018-09-13 Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats Yun, Jun-Won Kwon, Euna Kim, Yun-Soon Kim, Seung-Hyun You, Ji-Ran Kim, Hyoung-Chin Park, Jin-Sung Che, Jeong-Hwan Lee, Sang-Koo Jang, Ja-June Kim, Hyeon Hoe Kang, Byeong-Cheol BMC Complement Altern Med Research Article BACKGROUND: Seed of mature Croton tiglium Linne, also known as Tiglium seed (TS), has been widely used as a natural product due to its several health beneficial properties including anti-tumor and antifungal activities. Despite its ethnomedicinal beneficial properties, toxicological information regarding TS extract, especially its long-term toxicity, is currently limited. Therefore, the objective of the present study was to evaluate acute and subchronic toxicity of TS extract in rats after oral administration following test guidelines of the Organization for Economic Cooperation and Development (OECD). METHODS: Toxicological properties of TS extract were evaluated by toxicity assays to determine its single-dose acute toxicity (125, 250, 500, 1000, or 2000 mg/kg), 14-day repeated-dose toxicity (125, 250, 500, 1000, or 2000 mg/kg) and 13-week repeated-dose toxicity (31.25, 62.5, 125, 250, and 500 mg/kg) in Sprague-Dawley rats and F344 rats. Hematological, serum biochemical, and histopathological parameters were analyzed to determine its median lethal dose (LD(50)) and no-observed-adverse-effect-level (NOAEL). RESULTS: Oral single dose up to 2000 mg/kg of TS extract resulted in no mortalities or abnormal clinical signs. In 13-week toxicity study, TS extract exhibited no dose-related changes (mortality, body weight, food/water consumption, hematology, clinical biochemistry, organ weight, or histopathology) at dose up to 500 mg/kg, the highest dosage level suggested based on 14-day repeat-dose oral toxicity study. CONCLUSION: Acute oral LD(50) of TS extract in rats was estimated to be greater than 2000 mg/kg. NOAEL of TS extract administered orally was determined to be 500 mg/kg/day in both male and female rats. Results from these acute and subchronic toxicity assessments of TS extract under Good Laboratory Practice regulations indicate that TS extract appears to be safe for human consumption. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12906-018-2315-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-12 /pmc/articles/PMC6134578/ /pubmed/30208908 http://dx.doi.org/10.1186/s12906-018-2315-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Yun, Jun-Won Kwon, Euna Kim, Yun-Soon Kim, Seung-Hyun You, Ji-Ran Kim, Hyoung-Chin Park, Jin-Sung Che, Jeong-Hwan Lee, Sang-Koo Jang, Ja-June Kim, Hyeon Hoe Kang, Byeong-Cheol Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats |
title | Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats |
title_full | Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats |
title_fullStr | Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats |
title_full_unstemmed | Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats |
title_short | Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats |
title_sort | assessment of acute, 14-day, and 13-week repeated oral dose toxicity of tiglium seed extract in rats |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134578/ https://www.ncbi.nlm.nih.gov/pubmed/30208908 http://dx.doi.org/10.1186/s12906-018-2315-5 |
work_keys_str_mv | AT yunjunwon assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats AT kwoneuna assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats AT kimyunsoon assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats AT kimseunghyun assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats AT youjiran assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats AT kimhyoungchin assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats AT parkjinsung assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats AT chejeonghwan assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats AT leesangkoo assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats AT jangjajune assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats AT kimhyeonhoe assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats AT kangbyeongcheol assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats |